Editas Medicine to present LNP research at ESGCT congress in October

Go back to Editas Medicine to present LNP research at ESGCT congress in October

Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference

October 14, 2026 9:00 AM EDT

CAMBRIDGE, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced two poster presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress, to be held October 27-30, 2026, in Hamburg, Germany.

European Society of Gene and Cell Therapy (ESGCT) Congress
Title: Novel targeted LNP delivery achieved in vivo CAR-T cell generation resulting... More